These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29361388)

  • 21. Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.
    Burt HJ; Neuhoff S; Almond L; Gaohua L; Harwood MD; Jamei M; Rostami-Hodjegan A; Tucker GT; Rowland-Yeo K
    Eur J Pharm Sci; 2016 Jun; 88():70-82. PubMed ID: 27019345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions.
    Feng B; Varma MV
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S110-21. PubMed ID: 27385169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
    Tanihara Y; Masuda S; Katsura T; Inui K
    Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management.
    Gutiérrez F; Fulladosa X; Barril G; Domingo P
    AIDS Rev; 2014; 16(4):199-212. PubMed ID: 25350530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
    Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
    J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of trimethoprim on serum creatinine.
    Kastrup J; Petersen P; Bartram R; Hansen JM
    Br J Urol; 1985 Jun; 57(3):265-8. PubMed ID: 4005491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal tubular secretion of pramipexole.
    Knop J; Hoier E; Ebner T; Fromm MF; Müller F
    Eur J Pharm Sci; 2015 Nov; 79():73-8. PubMed ID: 26360835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging effects on the organic base transporter and stereoselective renal clearance.
    Ujhelyi MR; Bottorff MB; Schur M; Roll K; Zhang H; Stewart J; Markel ML
    Clin Pharmacol Ther; 1997 Aug; 62(2):117-28. PubMed ID: 9284847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Physiologically Based Model of Creatinine Renal Disposition to Integrate Current Knowledge of Systems Parameters and Clinical Observations.
    Scotcher D; Arya V; Yang X; Zhao P; Zhang L; Huang SM; Rostami-Hodjegan A; Galetin A
    CPT Pharmacometrics Syst Pharmacol; 2020 Jun; 9(6):310-321. PubMed ID: 32441889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The urinary excretion of metformin, ceftizoxime and ofloxacin in high serum creatinine rats: Can creatinine predict renal tubular elimination?
    Ma YR; Zhou Y; Huang J; Qin HY; Wang P; Wu XA
    Life Sci; 2018 Mar; 196():110-117. PubMed ID: 29355545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.
    Jia W; Du F; Liu X; Jiang R; Xu F; Yang J; Li L; Wang F; Olaleye OE; Dong J; Li C
    Drug Metab Dispos; 2015 May; 43(5):669-78. PubMed ID: 25710938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC.
    Sponfeldner MI; Andrikyan W; Maas R; Fromm MF
    Clin Pharmacol Ther; 2024 Nov; 116(5):1259-1268. PubMed ID: 38989645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter-Mediated Clearances.
    Emami Riedmaier A; Burt H; Abduljalil K; Neuhoff S
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7(Suppl Suppl 7):S132-42. PubMed ID: 27385171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No pharmacokinetic interaction between paliperidone extended-release tablets and trimethoprim in healthy subjects.
    Thyssen A; Cleton A; Talluri K; Leempoels J; Janssens L; Boom S; Eerdekens M
    Hum Psychopharmacol; 2009 Oct; 24(7):532-9. PubMed ID: 19693799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions.
    Naderer O; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2466-70. PubMed ID: 9371351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanistic Models as Framework for Understanding Biomarker Disposition: Prediction of Creatinine-Drug Interactions.
    Scotcher D; Arya V; Yang X; Zhao P; Zhang L; Huang SM; Rostami-Hodjegan A; Galetin A
    CPT Pharmacometrics Syst Pharmacol; 2020 May; 9(5):282-293. PubMed ID: 32410382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.
    Rasool MF; Khalil F; Läer S
    Clin Pharmacokinet; 2015 Sep; 54(9):943-62. PubMed ID: 25773479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple organic cation transporters contribute to the renal transport of sulpiride.
    Li L; Weng Y; Wang W; Bai M; Lei H; Zhou H; Jiang H
    Biopharm Drug Dispos; 2017 Dec; 38(9):526-534. PubMed ID: 28926871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity.
    Nakamura T; Yonezawa A; Hashimoto S; Katsura T; Inui K
    Biochem Pharmacol; 2010 Dec; 80(11):1762-7. PubMed ID: 20813096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.